Astrotech Q2 FY2026 R&D expense down 25% YoY; Tracer 1000 in 35 locations

ASTROTECH Corp

R&D expense $1.832M, down 25% from Q2 FY2025 as company transitions from development to commercial sales.
Tracer 1000 deployed in ~35 locations across 16 countries in US, Europe, Asia.
Appointed Scott Bartley as Interim CFO and David Spada as Director of Global Sales at 1st Detect.
CEO cites positive sales pipeline momentum in mass spectrometry and gas chromatography markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.